The Journal of Nutritional Biochemistry
Volume 18, Issue 7 , Pages 427-442 , July 2007

Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention

  • Sonia Ramos

      Affiliations

    • Corresponding Author InformationTel.: +34 91 544 56 07; fax: +34 91 549 36 27.

Received 7 September 2006 ,Revised 6 November 2006 ,Accepted 13 November 2006.

References 

  1. Watson W, Cai J, Jones D. Diet and apoptosis. Annu Rev Nutr. 2000;108:153–164
  2. Wenzel U, Kuntz S, Brendel M, Daniel H. Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells. Cancer Res. 2000;60:3823–3831
  3. Lopaczynski W, Zeisel S. Antioxidants, programmed cell death, and cancer. Nutr Res. 2001;21:295–307
  4. MacFarlane M, Williams A. Apoptosis and disease: a life or death decision. EMBO Rep. 2004;5:674–678
  5. Johnson I. Anticarcinogenic effects of diet-related apoptosis in the colorectal mucosa. Food Chem Toxicol. 2002;40:1171–1178
  6. Yang C, Landau J, Huang M, Newmark H. Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 2001;21:381–397
  7. Manson M. Cancer prevention — the potential for diet to modulate molecular signaling. Trends Mol Med. 2003;9:11–18
  8. Bravo L. Polyphenols: chemistry, dietary sources, metabolism and nutritional significance. Nutr Rev. 1998;56:317–333
  9. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans: I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81(Suppl):230S–242S
  10. Scalbert A, Morand C, Manach C, Rémésy C. Absorption and metabolism of polyphenols in the gut and impact on health. Biomed Pharmacother. 2002;56:276–282
  11. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr. 2004;79:727–747
  12. Sazuka M, Itoi T, Suzuki Y, Odani S, Koide T, Isemura M. Evidence for the interaction between (−)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen and histidine-rich glycoprotein. Biosci Biotechnol Biochem. 1996;60:1317–1319
  13. Goldbohm R, Hertog M, Brants H, van Poppel G, van den Brandt P. Consumption of black tea and cancer risk: a prospective cohort study. J Natl Cancer Inst. 1996;88:93–100
  14. Tsubono Y, Nishino Y, Komatsu S, Hsieh C, Kanemura S, Tsuji I, et al. Green tea and the risk of gastric cancer in Japan. N Engl J Med. 2001;344:632–636
  15. Garcia R, Gonzalez C, Agudo A, Riboli E. High intake of specific carotenoids and flavonoids does not reduce the risk of bladder cancer. Nutr Cancer. 1999;35:212–214
  16. Arts I, Holmann P, Bueno de Mesquita H, Feskens E, Kromhout D. Dietary catechins and epithelial cancer incidence: the Zutphen Elderly Study. Int J Cancer. 2001;92:298–302
  17. Garcia-Closas R, Agudo A, Gonzalez C, Riboli E. Intake of specific carotenoids and flavonoids and the risk of lung cancer in women in Barcelona, Spain. Nutr Cancer. 1998;32:154–158
  18. Arts I, Jacobs D, Gross M, Harnack L, Folsom A. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control. 2002;13:373–382
  19. De Stefani E, Roncoa A, Mendilaharsu M, Deneo-Pellegrini H. Diet and risk of cancer of the upper aerodigestive tract: II. Nutrients. Oral Oncol. 1999;35:22–26
  20. Garcia-Closas R, Gonzalez C, Agudo A, Riboli E. Intake of specific carotenoids and flavonoids and the risk of gastric cancer in Spain. Cancer Causes Control. 1999;10:71–75
  21. Imai K, Suga K, Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev Med. 1997;26:769–775
  22. Key T, Sharp G, Appleby P, Beral V, Goodman M, Soda M, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer. 1999;81:1248–1256
  23. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E, et al. Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol. 1997;146:223–230
  24. Knekt P, Kumpulainen J, Järvinen R, Rissanen H, Heliövaara M, Reunanen A, et al. Flavonoid intake and risk of chronic diseases. Am J Clin Nutr. 2002;76:560–568
  25. Su L, Arab L. Tea consumption and the reduced risk of colon cancer — results from a national prospective cohort study. Public Health Nutr. 2002;5:419–425
  26. Wakai K, Ohno Y, Genka K, Ohmine K, Kawamura T, Tamakoshi A, et al. Risk modification in lung cancer by a dietary intake of preserved foods and soyfoods: findings from a case–control study in Okinawa, Japan. Lung Cancer. 1999;25:147–159
  27. Le Marchand L, Murphy S, Hankin J, Wilkens L, Kolonel L. Intake of flavonoids and lung cancer. J Natl Cancer Inst. 2000;92:154–160
  28. Nakachi K, Suemasu K, Suga K, Takeo T, Imai K, Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn J Cancer Res. 1998;89:254–261
  29. Salti G, Grewal S, Mehta R, das Gupta T, Boddie A, Constantinou A. Genistein induces apoptosis and topoisomerase II-mediated DNA breakage in colon cancer cells. Eur J Cancer. 2000;36:796–802
  30. Snyder R, Gillies P. Reduction of genistein clastogenicity in Chinese hamster V79 cells by daidzein and other flavonoids. Food Chem Toxicol. 2003;41:1291–1298
  31. Chun H, Chang H-J, Choi E, Kim H, Ku K. Molecular and absorption properties of 12 soy isoflavones and their structure–activity relationship with selected biological activities. Biotechnol Lett. 2005;27:1105–1111
  32. Musonda C, Chipman J. Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-κB DNA binding activity and DNA damage in HepG2 cells. Carcinogenesis. 1998;19:1583–1589
  33. Abalea V, Cillard J, Dubos M-P, Sergent O, Cillard P, Morel I. Repair of iron-induced DNA oxidation by the flavonoid myricetin in primary rat hepatocyte cultures. Free Radic Biol Med. 1999;26:1457–1466
  34. Yi W, Fischer J, Krewer G, Akoh C. Phenolic compounds from blueberries can inhibit colon cancer cell proliferation and induce apoptosis. J Agric Food Chem. 2005;53:7320–7329
  35. Jakubowicz-Gil J, Paduch R, Piersiak T, Glowniak K, Gawron A, Kandefer-Szerszen M. The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells. Biochem Pharmacol. 2005;69:1343–1350
  36. Gupta S, Hussain T, Mukhtar H. Molecular pathway for (−)-epigallocatechin gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells. Arch Biochem Biophys. 2003;410:177–185
  37. Lee J, Kim J, Park J, Chung G, Jang Y. The antioxidant, rather than prooxidant, activities of quercetin on normal cells: quercetin protects mouse thymocytes from glucose oxidase-mediated apoptosis. Exp Cell Res. 2003;291:386–397
  38. Yin F, Giuliano A, Law R, Van Herle A. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. Anticancer Res. 2001;21:413–420
  39. Ong C, Tran E, Nguyen T, Ong C, Lee S, Lee J, et al. Quercetin-induced growth inhibition and cell death in nasopharyngeal carcinoma cells are associated with increase in Bad and hypophosphorylated retinoblastoma expressions. Oncol Rep. 2004;11:727–733
  40. Spencer J, Rice-Evans C, Williams R. Modulation of pro-survival Akt/protein kinase B and ERK1/2 signaling cascades by quercetin and its in vivo metabolites underlie their action on neuronal viability. J Biol Chem. 2003;278:34783–34793
  41. Gong L, Li Y, Nedeljkovic-Kurepa A, Sarkar F. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene. 2003;22:4702–4709
  42. Park S-Y, Seol D-W. Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis. Biochem Biophys Res Comm. 2002;295:515–518
  43. Lee K-T, Sohn I-C, Kim Y-K, Choi J-H, Choi J-W, Park H-J, et al. Tectorigenin, an isoflavone of Pueraria thunbergiana BENTH., induces differentiation and apoptosis in human promyelocytic leukemia HL-60 cells. Biol Pharm Bull. 2001;24:1117–1121
  44. Masuda M, Suzui M, Weinstein IB. Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathway, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 2001;7:4220–4229
  45. Kuo P-L, Lin C-C. Green tea constituent (−)-epigallocatechin-3-gallate inhibits HepG2 cell proliferation and induces apoptosis through p53-dependent and Fas-mediated pathways. J Biomed Sci. 2003;10:219–227
  46. Lee H-J, Wang C-J, Kuo H-C, Chou F-P, Jean L-F, Tseng T-H. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicol Appl Pharmacol. 2005;203:124–131
  47. Frey R, Singletary K. Genistein activates p38 mitogen-activated protein kinase, inactivates ERK1/ERK2 and decreases Cdc25C expression in immortalized human mammary epithelial cells. J Nutr. 2003;133:226–231
  48. Siddiqui I, Adhami V, Afaq F, Ahmad N, Mukhtar H. Modulation of phosphatidylinositol-3 kinase/protein kinase B- and mitogen-activated protein kinase-pathways by tea polyphenols in human prostate cancer cells. J Cell Biochem. 2004;91:232–242
  49. Shimizu M, Deguchi A, Lim JTE, Moriwaki H, Kopelovich L, Weinstein IB. (−) Epigallocatechin gallate and polyphenon E inhibit growth and activation of epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res. 2005;11:2735–2746
  50. Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, et al. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids. Cancer Res. 2006;66:4826–4834
  51. Lee L, Huang Y, Hwang J, Lee A, Ke F, Huang C, et al. Transinactivation of the epidermal growth factor receptor tyrosine kinase and focal adhesion kinase phosphorylation by dietary flavonoids: effect on invasive potential of human carcinoma cells. Biochem Pharmacol. 2004;67:2103–2114
  52. Kaneuchi M, Sasaki M, Tanaka Y, Sakuragi N, Fujimoto S, Dahiya R. Quercetin regulates growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int J Oncol. 2003;22:159–164
  53. Michels G, Watjen W, Niering P, Steffan B, Thi Q, Chovolou Y, et al. Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology. 2005;206:337–348
  54. Wang I, Lin-Shiau S, Lin J. Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer. 1999;35:1517–1525
  55. Abou-Agag L, Aikens M, Tabengwa E, Benza R, Shows S, Grenett H, et al. Polyphenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res. 2001;25:155–162
  56. Trompezinski S, Denis A, Schmitt D, Viac J. Comparative effects of polyphenols from green tea (EGCG) and soybean (genistein) on VEGF and IL-8 release from normal human keratinocytes stimulated with the proinflammatory cytokine TNF-α. Arch Dermatol Res. 2003;295:112–116
  57. Bagchi D, Sen C, Bagchi M, Atalay M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Moscow). 2004;69:75–80
  58. Kim N, Mehta R, Yu W, Neeman I, Livney T, Amichay A, et al. Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat. 2002;71:203–217
  59. Singh A, Seth P, Anthony P, Husain M, Madhavan S, Mukhtar H, et al. Green tea constituent epigallocatechin-3-gallate inhibits angiogenic differentiation of human endothelial cells. Arch Biochem Biophys. 2002;401:29–37
  60. Annabi B, Lachambre M, Bousquet-Gagnon N, Pagé M, Gingras D, Béliveau R. Green tea polyphenol (3)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim Biophys Acta. 2002;1542:209–220
  61. Toi M, Bando H, Ramachandran C, Melnick S, Imai A, Fife R, et al. Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis. 2003;6:121–128
  62. Ramos S, Alia M, Bravo L, Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J Agric Food Chem. 2005;53:1271–1280
  63. Yang C, Landau J. Effects of tea consumption on nutrition and health. J Nutr. 2000;130:2409–2412
  64. Brusselmans K, de Schrijver E, Heyns W, Verhoeven G, Swinnen J. Epigallocatechin-3-gallate is a potent natural inhibitor of fatty acid synthase in intact cells and selectively induces apoptosis in prostate cancer cells. Int J Cancer. 2003;106:856–862
  65. Chen Z, Schella J, Hob C, Chen K. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer Lett. 1998;129:173–179
  66. Chung J, Han J, Hwang E, Seo J, Cho K, Kim K, et al. Dual mechanism of green tea extract (EGCG)-induced cell survival in human epidermal keratinocytes. FASEB J. 2003;17:1913–1915
  67. Kawai K, Tsuno N, Kitayama J, Okaji Y, Yazawa K, Asakage M, et al. Epigallocatechin gallate induces apoptosis of monocytes. J Allergy Clin Immunol. 2005;115:186–191
  68. Hibasami H, Achiwa Y, Fujikawa T, Komiya T. Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res. 1996;16:1943–1946
  69. Kemberling J, Hampton J, Keck R, Gomez M, Selman S. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J Urol. 2003;170:773–776
  70. Nakagawa H, Hasumi K, Woo J, Nagai K, Wachi M. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (−)-epigallocatechin gallate. Carcinogenesis. 2004;25:1567–1574
  71. Chung L, Cheung T, Kong S, Fung K, Choy Y, Chan Z, et al. Induction of apoptosis by green tea catechins in human prostate cancer DU145 cells. Life Sci. 2001;68:1207–1214
  72. Horie N, Hirabayashi N, Takahashi Y, Miyauchi Y, Taguchi H, Takeishi K. Synergistic effect of green tea catechins on cell growth and apoptosis induction in gastric carcinoma cells. Biol Pharm Bull. 2005;28:574–579
  73. Chen C, Shen G, Hebbar V, Hu R, Owuor E, Kong A. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis. 2003;24:1369–1378
  74. Tan X, Hu D, Li S, Han Y, Zhang Y, Zhou D. Differences of four catechins in cell cycle arrest and induction of apoptosis in LoVo cells. Cancer Lett. 2000;158:1–6
  75. Yang G, Liao J, Kim K, Yurkow E, Yang C. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis. 1998;19:611–616
  76. Wu B-T, Hung P-F, Chen H-C, Huang R-N, Chang H-H, Kao Y-H. The apoptotic effect of green tea (−)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the Cdk2 pathway. J Agric Food Chem. 2005;53:5695–56701
  77. Hsu S, Bollag W, Huang L, Singh B, Sharawy M, Yamamoto T, et al. Green tea polyphenols induce differentiation and proliferation in epidermal keratinocytes. J Pharmacol Exp Ther. 2003;306:29–34
  78. Ahmad N, Feyes D, Nieminen A, Agarwal R, Mukhtar H. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. J Natl Cancer Inst. 1997;89:1881–1886
  79. Lamson D, Brignall M. Antioxidants and cancer: III. Quercetin. Altern Med Rev. 2000;5:196–208
  80. Spencer J, Chowrimootoo G, Choudhury R, Debnam E, Srai S, Rice-Evans C. The small intestine can both absorb and glucuronidate luminal flavonoids. FEBS Lett. 1999;458:224–230
  81. Van der Woude H, Gliszczynska-Swiglo A, Struijs K, Smeets A, Alink G, Rietjens I. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett. 2003;200:41–47
  82. Elattar T, Virji A. The inhibitory effect of curcumin, genistein, quercetin and cisplatin on the growth of oral cancer cells in vitro. Anticancer Res. 2000;20:1733–1738
  83. Wätjen W, Michels G, Steffan B, Niering P, Chovolou Y, Kampkötter A, et al. Low concentrations of flavonoids are protective in rat H4IIE cells whereas high concentrations cause DNA damage and apoptosis. J Nutr. 2005;135:525–531
  84. Kong A, Yu R, Chen C, Mandlekar S, Primiano T. Signal transduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch Pharm Res. 2000;23:1–16
  85. Nair H, Rao K, Aalinkeel R, Mahajan S, Chawda R, Schwartz S. Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes. Clin Diagnostic Lab Immunol. 2004;11:63–69
  86. Chowdhury S, Kishino K, Satoh R, Hashimoto K, Kikuchi H, Nishikawa H, et al. Tumor-specificity and apoptosis-inducing activity of stilbenes and flavonoids. Anticancer Res. 2005;25:2055–2063
  87. Sarkar F, Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 2002;21:265–280
  88. Zava D, Duwe G. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 1997;27:31–40
  89. Dampier K, Hudson E, Howells L, Manson M, Walker R, Gescher A. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br J Cancer. 2001;85:618–624
  90. Maggiolini M, Bonofiglio D, Marsico S, Panno M, Cenni B, Picard D, et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol. 2001;60:595–602
  91. Chen A-C, Donovan S. Genistein at a concentration present in soy infant formula inhibits Caco-2Bbe cell proliferation by causing G2/M cell cycle arrest. J Nutr. 2004;134:1303–1308
  92. Shen J-C, Klein R, Wei Q, Guan Y, Contois J, Wang T, et al. Low-dose genistein induces cyclin-dependent kinase inhibitors and G1 cell-cycle arrest in human prostate cancer cells. Mol Carcinog. 2000;29:92–102
  93. Li Y, Sarkar F. Inhibition of nuclear factor κB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res. 2002;8:2369–2377
  94. Debatin K-M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004;53:153–159
  95. Johnstone R, Ruefli A, Lowe S. Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002;108:153–164
  96. Valcic S, Timmermann B, Alberts D, Wachter G, Krutzsch M, Wymer J, et al. Inhibitory effect of six green tea catechins and caffeine on the growth of four selected human tumor cell lines. Anticancer Drugs. 1996;7:461–468
  97. Elattar T, Virji A. Effect of tea polyphenols on growth of oral squamous carcinoma cells in vitro. Anticancer Res. 2000;20:3459–3465
  98. Van Erk M, Roepman P, van der Lende T, Stierum R, Aarts J, van Bladeren P, et al. Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005;44:143–156
  99. Chen D, Daniel K, Chen M, Kuhn D, Landis-Piwowar K, Dou Q. Dietary flavonoids as proteasome inhibitors and apoptosis inducers in human leukemia cells. Biochem Pharmacol. 2005;69:1421–1432
  100. Mertens-Talcott S, Percival S. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett. 2005;218:141–151
  101. Shen S, Chen Y, Hsu F, Lee W. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade. J Cell Biochem. 2003;89:1044–1055
  102. Hakimuddin F, Paliyath G, Meckling K. Selective cytotoxicity of a red grape wine flavonoid fraction against MCF-7 cells. Breast Cancer Res Treat. 2004;85:65–79
  103. Chan M, Fong D, Soprano K, Holmes W, Heverling H. Inhibition of growth and sensitization to cisplatin-mediated killing of ovarian cancer cells by polyphenolic chemopreventive agents. J Cell Physiol. 2003;194:63–70
  104. Nguyen T, Tran E, Nguyen T, Do P, Huynh T, Huynh H. The role of activated MEK–ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004;25:647–659
  105. Chi C, Chang Y, Ou Y, Hsieh C, Lui Y, Peng F, et al. Effect of quercetin on the in vitro and in vivo growth of mouse hepatoma cells. Oncol Res. 1997;4:1021–1024
  106. Kuo S. Antiproliferative potency of structurally distinct dietary flavonoids on human colon cancer cells. Cancer Lett. 1996;110:41–48
  107. Herzog A, Kuntz S, Daniel H, Wenzel U. Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004;109:220–229
  108. Vijayababu M, Kanagaraj P, Arunkumar A, Ilangovan R, Aruldhas M, Arunakaran J. Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression. J Cancer Res Clin Oncol. 2005;131:765–771
  109. Huynh H, Nguyen T, Chan E, Tran E. Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor alpha (TGF-alpha)- and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation. Int J Oncol. 2003;23:821–829
  110. Zhang X-M, Chen J, Xia Y-G, Xu Q. Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-alfa and translocating PKC-delta. Cancer Chemother Pharmacol. 2005;55:251–262
  111. Csokay B, Prajda N, Weber G, Olah E. Molecular mechanisms in the antiproliferative action of quercetin. Life Sci. 1997;60:2157–2163
  112. Mouria M, Gukovskaya A, Jung Y, Buechler P, Hines O, Reber H, et al. Food-derived polyphenols inhibit pancreatic cancer growth through mitochondrial cytochrome c release and apoptosis. Int J Cancer. 2002;98:761–769
  113. Lian F, Li Y, Bhuiyan M, Sarkar F. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr Cancer. 1999;33:125–131
  114. Li Y, Upadhyay S, Bhuiyan M, Sarkar F. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 1999;18:3166–3172
  115. Xu J, Loo G. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J Cell Biochem. 2001;82:78–88
  116. Kumi-Diaka J, Sanderson N-A, Hall A. The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU145 and LNCaP. Biol Cell. 2000;92:595–604
  117. Onozawa M, Fukuda K, Ohtani M, Akaza H, Sugimura T, Wakabayashi K. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP. Jpn J Clin Oncol. 1998;360–363
  118. Alhasan S, Pietrasczkiwicz H, Alonso M, Ensley J, Sarkar F. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr Cancer. 1999;34:12–19
  119. Alhasan S, Ensley J, Sarkar F. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int J Oncol. 2000;16:333–338
  120. Yanagihara K, Ito A, Toge T, Numoto M. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract. Cancer Res. 1993;53:5815–5821
  121. Traganos F, Ardelt B, Halko N, Bruno S, Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 1992;52:6200–6208
  122. Su S-J, Yeh T-M, Lei H-Y, Chow N-H. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer. Clin Cancer Res. 2002;6:230–236
  123. Brown A, Jolly P, Wei H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis. 1998;19:991–997
  124. Nishikawa T, Nakajima T, Moriguchi M, Jo M, Sekoguchi S, Ishii M, et al. A green tea polyphenol, epigallocatechin-3-gallate, induces apoptosis of human hepatocellular carcinoma, possibly through inhibition of Bcl-2 family proteins. J Hepatol. 2006;44:1074–1082
  125. Hsu S, Lewis J, Singh B, Schoenlein P, Osaki T, Athar M, et al. Green tea polyphenol targets the mitochondria in tumor cells inducing caspase 3-dependent apoptosis. Anticancer Res. 2003;23:1533–1540
  126. Russo M, Palumbo R, Tedesco I, Mazzarella G, Russo P, Iacomino G, et al. Quercetin and anti-CD95(Fas/Apo1) enhance apoptosis in HPB-ALL cell line. FEBS Lett. 1999;462:322–328
  127. Kumi-Diaka J, Butler A. Caspase-3 protease activation during the process of genistein-induced apoptosis in TM4 testicular cells. Biol Cell. 2000;92:115–124
  128. Baxa D, Luo X, Yoshimura F. Genistein induces apoptosis in T lymphoma cells via mitochondrial damage. Nutr Cancer. 2005;51:93–101
  129. Chang J, Hsu Y, Kuo P, Kuo Y, Chiang L, Lin C. Increase of Bax/ Bcl-xL ratio and arrest of cell cycle by luteolin in immortalized human hepatoma cell line. Life Sci. 2005;76:1883–1893
  130. Leone M, Zhai D, Sareth S, Kitada S, Reed J, Pellecchia M. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Cancer Res. 2003;63:8118–8121
  131. Roy A, Baliga M, Katiyar S. Epigallocatechin-3-gallate induces apoptosis in estrogen receptor-negative human breast carcinoma cells via modulation in protein expression of p53 and Bax and caspase-3 activation. Mol Cancer Ther. 2005;4:81–90
  132. Hayakawa S, Saeki K, Sazuka M, Suzuki Y, Shoji Y, Ohta T, et al. Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun. 2001;285:1102–1106
  133. Kim W, Bang M, Kim E, Kang N, Jung K, Cho H, et al. Quercetin decreases the expression of ErbB2 and ErbB3 proteins in HT-29 human colon cancer cells. J Nutr Biochem. 2005;16:155–162
  134. Linford N, Yang Y, Cook D, Dorsa DM. Neuronal apoptosis resulting from high doses of the isoflavone genistein: role for calcium and P42/44 mitogen-activated protein kinase. J Pharmacol Exp Ther. 2001;299:67–75
  135. Baxa D, Yoshimura F. Genistein reduces NF-κB in T lymphoma cells via a caspase-mediated cleavage of IκBa. Biochem Pharmacol. 2003;66:1009–1018
  136. Constantinou A, Kamath N, Murley J. Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur J Cancer. 1998;34:1927–1934
  137. Leung L, Wang T. Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. J Nutr. 2000;130:2922–2926
  138. Yu Z, Li W, Liu F. Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells. Cancer Lett. 2004;215:159–166
  139. Suganuma M, Okabe S, Kai Y, Sueoka N, Sueoka E, Fujiki H. Synergistic effects of (−)-epigallocatechin gallate with (−)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9. Cancer Res. 1999;59:44–47
  140. Khafif A, Schantz S, Chou T, Edelstein D, Sacks P. Quantitation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells. Carcinogenesis. 1998;19:419–424
  141. Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005;4:949–955
  142. Sakamoto K. Synergistic effects of thearubigin and genistein on human prostate tumor cell (PC-3) growth via cell cycle arrest. Cancer Lett. 2000;151:103–109
  143. Mohammad R, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar F. Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts. Cancer. 2006;106:1260–1268
  144. Tamura S, Bito T, Ichihashi M, Ueda M. Genistein enhances the cisplatin-induced inhibition of cell growth and apoptosis in human malignant melanoma cells. Pigment Cell Res. 2003;16:470–476
  145. Hwang J-T, Ha J, Park O. Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Comm. 2005;332:433–440
  146. Weinreb O, Mandel S, Youdim M. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J. 2003;17:935–937
  147. Vittal R, Selvanayagam Z, Sun Y, Hong J, Liu F, Chin K, et al. Gene expression changes induced by green tea polyphenol (−)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray. Mol Cancer Ther. 2004;3:1091–1099
  148. Okabe S, Fujimoto N, Sueoka N, Suganuma M, Fujiki H. Modulation of gene expression by (2)-epigallocatechin gallate in PC-9 cells using a cDNA expression array. Biol Pharm Bull. 2001;24:883–886
  149. Wenzel U, Herzog A, Kuntz S, Daniel H. Protein expression profiling identifies molecular targets of quercetin as a major dietary flavonoid in human colon cancer cells. Proteomics. 2004;4:2160–2174
  150. Murtaza I, Marra G, Schlapbach R, Patrignani A, Kunzli M, Wagner U, et al. A preliminary investigation demonstrating the effect of quercetin on the expression of genes related to cell-cycle arrest, apoptosis and xenobiotic metabolism in human CO115 colon-adenocarcinoma cells using DNA microarray. Biotechnol Appl Biochem. 2006;45:29–36
  151. Li Y, Sarkar F. Gene expression profiles of genistein-treated PC3 prostate cancer cells. J Nutr. 2002;132:3623–3631
  152. Yang C, Chen L, Lee M-J, Balentine D, Kuo M, Schantz S. Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomarkers Prev. 1998;7:351–354
  153. Chow H-H, Cai Y, Alberts D, Hakim I, Dorr R, Shahi F, et al. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol Biomarkers Prev. 2001;10:53–58
  154. Jatoi A, Ellison N, Burch P, Sloan J, Dakhil S, Novotny P, et al. A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer. 2003;97:1442–1446
  155. Pisters K, Newman R, Coldman B, Shin D, Khuri F, Hong W, et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001;19:1830–1838
  156. Takimoto C, Glover K, Huang X, Hayes S, Gallot L, Quinn M, et al. Phase I pharmacokinetic and pharmacodynamic analysis of unconjugated soy isoflavones administered to individuals with cancer. Cancer Epidemiol Biomarkers Prev. 2003;12:1213–1221
  157. Mulholland P, Ferry D, Anderson D, Hussain S, Young A, Cook J, et al. Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann Oncol. 2001;12:245–248
  158. Ferry D, Anderson M, Beddows K, Mayer P, Price L, Jankowski J. Phase II trial of gefitinib (ZD1839) in advanced adenocarcinoma of the oesophagus incorporating biopsy before and after gefitinib. J Clin Oncol. 2004;22:4021
  159. Chang H, Doerge D. Dietary genistein inactivates rat thyroid peroxidase in vivo without an apparent hypothyroid effect. Toxicol Appl Pharmacol. 2000;168:244–252

PII: S0955-2863(06)00264-6

doi: 10.1016/j.jnutbio.2006.11.004

The Journal of Nutritional Biochemistry
Volume 18, Issue 7 , Pages 427-442 , July 2007

Article Tools

* Image Usage & Resolution